RTSN · Retension Pharmaceuticals, Inc. · Analyst Estimates
Market Cap
$134.81M
Shares
8.33M
Volume · Oct 20
98.33K
Avg daily vol (8 sessions)
235.94K
Analyst Estimates
Compare analyst forecasts for Retension Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Published by the company
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.